Serum B12 tells you how much cobalamin is circulating; active B12 and MMA tell you whether enough is reaching cells. That distinction matters when numbness, fatigue, brain fog, metformin use, vegan diets, or gut surgery make a normal-looking B12 result hard to trust.
- Active B12 test measures holotranscobalamin, the cell-deliverable fraction of B12; many labs treat <35 pmol/L as low and 35-50 pmol/L as borderline.
- MMA test measures methylmalonic acid; serum MMA above about 0.40 µmol/L supports cellular B12 deficiency when kidney function is normal.
- Сывороткалык B12 can look normal at 300-500 pg/mL while symptoms persist, especially after recent supplements or in liver disease, kidney disease, or altered binding proteins.
- Холотранскобаламин often falls before anemia appears because it reflects B12 available to tissues rather than total circulating B12.
- Methylmalonic acid test is more functional but less specific in chronic kidney disease; eGFR below 60 mL/min/1.73 m² can raise MMA without true B12 deficiency.
- CBC results may be completely normal in early B12 deficiency; MCV above 100 fL is a late clue, not a screening guarantee.
- Жогорку тобокелдик топтор include vegans, people after bariatric surgery, older adults, metformin users, long-term acid blocker users, and patients with autoimmune gastritis or ileal disease.
- Кийинки текшерүү is usually most useful 8-12 weeks after consistent B12 treatment, with MMA expected to fall earlier than MCV or neurological recovery.
When a Normal Serum B12 Result Is Not Enough
A normal serum B12 result does not always exclude functional deficiency. If symptoms or risk factors fit, an active B12 test for holotranscobalamin plus an MMA test can show whether B12 is actually reaching cells. As of May 28, 2026, I usually trust the pair more than total B12 alone when the result sits in the grey zone.
Serum B12 usually reports total cobalamin, with many laboratories using roughly 200-900 пг/мл же 148–665 пмоль/л as an adult reference interval. Kantesti is an AI кан анализи анализатору that flags a normal-looking B12 result differently when neuropathy, macrocytosis, metformin use, or a vegan diet appear in the same report or patient history; our organization details are available on Биз жөнүндө.
I’m Thomas Klein, MD, and the pattern I see most often is not dramatic: a 41-year-old patient with tingling feet, serum B12 of 382 pg/mL, MCV of 91 fL, and no anemia. The usual single-number answer says “normal,” but their holotranscobalamin returns 24 pmol/L and MMA 0.62 µmol/L, which changes the clinical conversation completely.
Stabler’s 2013 New England Journal of Medicine review described the same problem clinically: neurological B12 deficiency can occur without classic anemia, and biomarkers have to be interpreted in combination rather than as isolated proof (Stabler, 2013). If your symptoms match that pattern, our deeper piece on normal B12 symptoms боюнча колдонмо пайдалуу кошумча болуп саналат.
What Holotranscobalamin Actually Measures
Holotranscobalamin measures the fraction of vitamin B12 attached to transcobalamin, the carrier that delivers B12 into cells. This is why it is often called active B12, even though it represents only about 10-30% of circulating B12.
Total B12 includes B12 bound to haptocorrin, a carrier that stores or transports B12 but does not efficiently deliver it into most cells. Holotranscobalamin is the smaller, clinically interesting fraction because cells take up the transcobalamin-B12 complex through receptor-mediated transport.
A common adult holotranscobalamin reference pattern is >50 pmol/L as generally adequate, 35-50 pmol/L as indeterminate, and <35 pmol/L as suspicious for deficiency. Some European laboratories use different assay-specific cutoffs, so a value of 38 pmol/L may be labelled “borderline” in one report and “low-normal” in another.
The British Committee for Standards in Haematology guideline led by Devalia in 2014 recommended considering MMA or holotranscobalamin when serum B12 is equivocal and clinical suspicion remains (Devalia et al., 2014). For readers comparing older B12 reports with newer assays, our витамин B12 анализи guide explains why reference intervals are not interchangeable.
In Kantesti AI review sessions, I see holotranscobalamin behave like a supply-chain marker: it often drops before the warehouse looks empty. That is clinically handy, but it is not perfect; pregnancy, recent supplementation, and assay variation can all blur the signal.
What the MMA Test Adds to Active B12
The MMA test measures methylmalonic acid, which rises when cells lack enough B12 to run methylmalonyl-CoA mutase. In adults with normal kidney function, serum MMA above about 0.40 мкмоль/л is a strong clue for cellular B12 deficiency.
MMA is not a vitamin level; it is a metabolic back-pressure marker. When intracellular B12 is inadequate, methylmalonyl-CoA is not converted efficiently to succinyl-CoA, and methylmalonic acid spills upward in serum or urine.
Many laboratories report serum MMA reference intervals around 0.00-0.40 µmol/L, while some use upper limits closer to 0.28 µmol/L. жогору болгондо пайда болот. Натыйжа 0.52 µmol/L is more persuasive when eGFR is 92 mL/min/1.73 m² than when eGFR is 42 mL/min/1.73 m².
Hannibal and colleagues’ 2016 Frontiers in Molecular Biosciences review emphasized that no single B12 biomarker is ideal, and diagnostic algorithms perform better when MMA, holotranscobalamin, total B12, renal function, and symptoms are combined (Hannibal et al., 2016). Our B12 диапазон боюнча колдонмо covers the total B12 side of that algorithm.
In practice, I treat MMA as a functional smoke alarm rather than a standalone diagnosis. It tells me something is burning in the B12 pathway, but I still check whether kidney function, dehydration, small intestinal bacterial overgrowth, or rare metabolic conditions could be making the alarm too sensitive.
How to Interpret Holotranscobalamin and MMA Together
Low holotranscobalamin plus high MMA is the clearest lab pattern for functional B12 deficiency. Normal holotranscobalamin with normal MMA makes clinically significant deficiency less likely, though it does not explain every neurological symptom.
The most useful pair is холотранскобаламин <35 pmol/L менен MMA >0.40 µmol/L, especially when eGFR is above 60 мл/мин/1.73 м². That combination suggests poor B12 delivery and a measurable metabolic consequence.
A low active B12 with normal MMA often means early deficiency, recent dietary change, pregnancy-related dilution, or a lab grey zone. I would not dismiss symptoms in that situation; I would ask about nitrous oxide exposure, gastric surgery, autoimmune disease, and whether supplements were started before testing.
High MMA with normal active B12 is the tricky box. In a patient with numbness or balance symptoms, I re-check total B12, folate, eGFR, and sometimes homocysteine; our guide to numbness lab clues кеңири дифференциалды түшүндүрөт.
Reference Ranges and Grey Zones Across Labs
Active B12 and MMA cutoffs vary because assays, populations, and units differ between laboratories. A holotranscobalamin value of 42 pmol/L or an MMA of 0.36 µmol/L should be read as a probability signal, not a verdict.
Serum B12 may be reported in пг/млде билдирет, нг/л, же пмоль/л; 1 pg/mL is approximately 0.738 pmol/L for cobalamin. Holotranscobalamin is usually reported in пмоль/л, while MMA is commonly reported in мкмоль/л же нмоль/л.
The practical grey zone for total B12 is often 200-350 пг/мл, but I have seen symptomatic patients with functional markers abnormal at 450 пг/млден жогору after taking multivitamins. A recent oral B12 dose of 500-1000 µg can lift serum B12 before MMA has fully normalized.
Kantesti’s neural network checks units before interpreting a result because unit mismatch is one of the dullest but most dangerous lab-report errors. If you are comparing reports from different countries, our article on лабораториянын бирдиктерин өзгөртүү боюнча колдонмолорубузду окуп чыгууга арзыйт. can prevent a false alarm.
Symptoms That Justify Functional B12 Testing
Functional B12 testing is reasonable when neurological symptoms persist despite a normal serum B12 result. Tingling, burning feet, balance problems, memory change, glossitis, unexplained fatigue, and new low mood are the symptoms I take most seriously.
B12-related nerve symptoms often start symmetrically in the toes or soles and may progress slowly over жумалардан айларга чейин. The uncomfortable truth is that neurological recovery can lag behind lab correction by 3-12 айда, and some deficits can persist if treatment is delayed.
Fatigue alone is nonspecific, but fatigue plus sore tongue, pins-and-needles, memory fog, and borderline MCV is a different story. In my experience, the “I feel wired and weak at the same time” description often overlaps with B12, thyroid, ferritin, sleep disruption, or glucose swings.
A normal active B12 and MMA pair does not mean symptoms are imaginary. It means the B12 pathway is less likely to be the main driver, and a broader workup such as чарчоо боюнча кан анализдери may be more helpful.
Risk Factors That Make Serum B12 Falsely Reassuring
Serum B12 is more likely to mislead in people with low intake, poor absorption, altered binding proteins, or recent supplementation. Vegans, older adults, metformin users, acid-blocker users, and patients after bariatric or ileal surgery deserve a lower threshold for active B12 and MMA testing.
Кантести - бул AI кан анализинин жыйынтыгы платформасы that treats B12 differently when a patient’s history includes vegan eating for more than 1-2 жылдын ичинде,, gastric bypass, ileal resection, coeliac disease, Crohn’s disease, or autoimmune gastritis. Those risk factors can lower tissue B12 before the serum value crosses the laboratory’s red line.
Metformin is a common one. After 4-5 жыл of regular use, B12 deficiency becomes clinically relevant enough that many clinicians check B12 periodically, especially when neuropathy appears in a person whose glucose numbers look stable.
Long-term proton pump inhibitors and H2 blockers reduce gastric acid, which can impair release of food-bound B12. People following plant-based diets should also read our practical веган лабораториялык текшерүү тизмеси, because ferritin, iodine, vitamin D, and omega-3 status often travel with the same story.
Kidney Function and Other Causes of High MMA
High MMA is less specific when kidney function is reduced. eGFR 60 мл/мин/1.73 м² can raise methylmalonic acid because the kidneys clear MMA less efficiently, even when B12 delivery is adequate.
A serum MMA of 0.55 µmol/L with eGFR 95 means something different from the same MMA with eGFR 38. In older adults, this distinction is not academic; mild chronic kidney disease is common and can convert a borderline MMA into a false B12 alarm.
Dehydration, recent intense exercise, and acute illness can also distort the metabolic context, although they are less classic confounders than kidney function. I usually want creatinine, eGFR, hydration clues, and sometimes cystatin C before calling a borderline MMA diagnostic.
If kidney numbers are changing, compare the MMA with a proper renal trend rather than a single creatinine. Our курак боюнча eGFR article explains why a creatinine that looks “normal” can still hide reduced filtration in a smaller or older person.
Why CBC Results Can Be Normal in B12 Deficiency
A normal CBC does not rule out early or neurological B12 deficiency. Macrocytosis, usually defined as MCV above 100 fLден жогору көтөрүлүп жатса, is a late or inconsistent sign and can be masked by iron deficiency or thalassaemia trait.
Classic teaching says B12 deficiency causes macrocytic anemia, but real patients are messier. A person with low ferritin may have smaller cells, while B12 deficiency pushes cell size upward; the average MCV can land at 88-94 fL and look deceptively tidy.
I pay attention to RDW, neutrophil morphology if a smear is done, hemoglobin trend, and platelet count, not just MCV. An MCV rise from 84 to 96 fL over two years may matter even if the lab never prints an H flag.
The pattern of B12 deficiency without anemia deserves respect because nerves can be affected before hemoglobin falls below 12 г/дл же 13 g/dL in men. For a deeper look at this mismatch, see our article on анемиясыз B12.
Homocysteine, Folate, and the MTHFR Distraction
Homocysteine can support a B12 diagnosis, but it is less specific than MMA. Levels above about 15 µmol/L may reflect B12 deficiency, folate deficiency, B6 deficiency, hypothyroidism, kidney disease, genetics, smoking, or medication effects.
MMA is more specific to B12-dependent methylmalonyl-CoA metabolism, while homocysteine sits at a busy crossroads involving B12, folate, B6, thyroid status, renal function, and inflammation. That is why a homocysteine of 18 µmol/L is useful but not decisive.
Folate can partly correct the anemia of B12 deficiency while neurological injury continues, which is why high-dose folic acid without B12 assessment makes me uneasy in symptomatic patients. This is especially relevant when folate is >20 нг/мл болгондо күчөйт. and B12 markers are borderline.
MTHFR results can distract from the immediate clinical question: is there enough functional B12 in cells today? Our homocysteine range колдонмо жана folate comparison piece explain where genetics fits, and where it really does not.
Testing Logistics: Fasting, Units, and Retesting
Active B12 and MMA usually do not require fasting, but timing still matters. Recent high-dose B12 supplements can raise serum B12 and holotranscobalamin within days, while MMA may take 1-3 жума to fall after effective treatment.
If you have not started supplements and symptoms are stable, testing before treatment gives the cleanest baseline. If you already took 1000 µg/day of B12 for two weeks, a normal serum B12 does not prove the original status was normal.
Serum MMA is usually preferred over urine MMA for routine adult interpretation because it is easier to pair with eGFR and other serum markers. Urine MMA can be useful in specific settings, but hydration and creatinine correction become part of the story.
Fasting is usually more relevant to glucose, lipids, and some metabolic panels than to B12 markers. Our орозо кармоо боюнча тест эрежелерибиз article explains which results shift after meals and which usually do not.
What Follow-Up Looks Like After B12 Treatment
MMA usually improves before symptoms fully recover after B12 treatment. A practical follow-up interval is 8-12 жумада кайра текшерүү керек after consistent oral or injectable therapy, unless neurological symptoms are worsening and need earlier medical review.
Oral cyanocobalamin or methylcobalamin doses of 1000-2000 µg/day can work well for many patients because passive absorption still occurs at high doses. In pernicious anemia, severe neurological symptoms, or post-bariatric malabsorption, clinicians may choose injections such as 1000 µg on a structured schedule.
I do not expect numbness to vanish in a week. Reticulocytes may rise within 5-10 күндө if anemia is present, MMA may fall within 1-3 жума, and neurological recovery often takes 3-12 айда depending on duration and severity.
Thomas Klein, MD advice here is deliberately boring: do not chase daily symptom swings with daily supplement changes. Use a stable plan, document dose and form, then compare objective markers using our төмөн B12 кошумчасы боюнча колдонмону follow-up framework.
How Kantesti Reads Active B12 Results in Context
Kantesti interprets active B12 test results by combining holotranscobalamin, MMA, total B12, CBC indices, kidney function, medications, diet pattern, and symptom clues. That context-based reading is safer than treating any single number as a diagnosis.
Кантести - бул AI менен иштеген кан анализин талдоо куралы used by more than 2M people аркылуу 127+ өлкө, and our B12 logic is designed to avoid both under-calling neuropathy risk and over-calling deficiency in kidney disease. The marker library behind that work is described in our биомаркерлер боюнча колдонмо.
Our AI biomarker interpretation platform does not mark MMA high in isolation and stop there. It checks whether eGFR is below 60, whether MCV has drifted upward by 5-10 fL, whether ferritin or folate could mask anemia, and whether metformin or acid blockers are visible in the medication history.
The clinical standards behind Kantesti AI are reviewed against physician-led benchmarks, including our медициналык текшерүү process. We also publish validation work such as the AI кыймылдаткычынын (engine) салыштырма текшерүүсү, which describes rubric-based testing across anonymised blood test cases.
When to Seek Medical Care and What to Ask
Seek medical care promptly if B12-related symptoms are progressive, neurological, or paired with anemia. New difficulty walking, falls, weakness, confusion, severe numbness, or hemoglobin below about 10 г/дЛ deserves clinician review rather than supplement trial-and-error.
Bring three questions: What is my holotranscobalamin? What is my MMA with eGFR? Could iron, folate, thyroid disease, diabetes, alcohol, medications, or autoimmune gastritis explain this pattern? A focused conversation saves weeks of guessing.
If the results are mixed, ask whether repeat testing after 8-12 жумада кайра текшерүү керек of consistent treatment is appropriate and whether pernicious anemia testing is needed. Intrinsic factor antibody is specific but not perfectly sensitive; a negative result does not always end the investigation.
Kantesti’s medical content is reviewed with physician oversight, including input from our Медициналык кеңеш. Thomas Klein, MD bottom line: if serum B12 looks normal but your story sounds like B12 deficiency, active B12 plus MMA is one of the cleanest ways to move from vague worry to a testable plan.
Көп берилүүчү суроолор
Сарысудагы B12 деңгейі қалыпты болған жағдайда B12 тапшылығы болуы мүмкін бе?
Ооба, функционалдык B12 жетишсиздиги сарысудагы B12 нормалдуу болгондо да пайда болушу мүмкүн, айрыкча натыйжа болжол менен 200–500 пг/мл чегаралык диапазондо болсо жана симптомдор же коркунуч факторлору бар болсо. Сарысудагы B12 жалпы айлануучу кобаламинди өлчөйт, клеткаларга жеткирилген көлөмдү сөзсүз эле эмес. Төмөн холотранскобаламин, көбүнчө 35 пмоль/лден төмөн, жана MMA болжол менен 0.40 мкмоль/лден жогору болсо, бөйрөк функциясы нормалдуу болгондо, ткандардын деңгээлинде B12 жетишсиздигин колдойт.
Активдүү B12 анализи эмнени өлчөйт?
Активдүү B12 тест холотранскобаламинди өлчөйт — транскобаламинге бириккен жана клеткалар тарабынан кабыл алууга жеткиликтүү болгон В12 витамининин фракциясын. Холотранскобаламин адатта жалпы айланма B12нин болжол менен 10–30%ын түзөт. Көптөгөн лабораториялар 50 пмоль/лден жогору көрсөткүчтөрдү жетиштүү деп, 35–50 пмоль/лди чек ара (borderline) деп, ал эми 35 пмоль/лден төмөн көрсөткүчтөрдү жетишсиздикке шектүү деп чечмелешет.
MMA тести сарысудагы B12 тестине караганда жакшыраакпы?
MMA тести көбүнчө функционалдык В12 жетишсиздигин аныктоо үчүн жакшыраак, анткени метилмалон кислотасы клеткалардын ичинде В12-ге көз каранды метаболизм жайлаганда көтөрүлөт. Сарысудагы MMA болжол менен 0,40 мкмоль/лден жогору болсо, eGFR нормалдуу болгондо В12 жетишсиздигин колдойт. MMA кемчиликсиз эмес, анткени өнөкөт бөйрөк оорусу, айрыкча eGFR 60 мл/мин/1,73 м²ден төмөн болсо, чыныгы В12 жетишсиздигисиз эле MMAны көтөрүшү мүмкүн.
Кайсы MMA деңгээли B12 жетишсиздигин көрсөтөт?
Сарысудағы MMA деңгейі шамамен 0,40 мкмоль/л-ден жоғары болуы бүйрек қызметі қалыпты ересектерде функционалдық В12 тапшылығының ықтималдығын көрсетеді. Кейбір зертханалар жоғарғы шектің төменірек мәндерін, мысалы 0,28 мкмоль/л, қолданады, сондықтан зертхананың өз анықтамалық диапазоны маңызды. Нәтиже холотранскобаламин 35 пмоль/л-ден төмен болғанда, сәйкес келетін симптомдармен және eGFR 60 мл/мин/1,73 м²-ден жоғары болғанда ең айқын болады.
Бөйрөк оорусу метилмалон қышқылынын анализи жогору болушуна себеп болобу?
Ооба, бөйрек ауруы метилмалон қышқылын арттыруы мүмкін, өйткені ММА-ның бір бөлігі бүйрек арқылы шығарылады. eGFR көрсеткіші 60 мл/мин/1,73 м²-ден төмен болғанда, ММА-ның сәл жоғары болуы В12 тапшылығы үшін спецификалық емес болып қалады. Мұндай жағдайда клиницистер әдетте ММА-ны холотранскобаламинмен, жалпы В12-мен, CBC динамикасымен, симптомдармен және кейде гомоцистеинмен бірге түсіндіреді.
Активдүү B12 же MMA тестинен мурда B12 кошулмаларын токтотушум керекпи?
Дарыгердин кеңешисиз дайындалган B12 дарылоону токтотпоңуз, айрыкча неврологиялык белгилер болсо. Эгер сиз жакында эле рецептсиз B12ди баштаган болсоңуз, муну дарыгериңизге айтыңыз, анткени 500–1000 мкг/күн кандагы B12 жана голотранскобаламинди бир нече күндүн ичинде көтөрө алат. Натыйжалуу дарылоодон кийин MMAнын жакшырышы үчүн 1–3 жума талап кылынышы мүмкүн, ошондуктан кошумчаны ичүү убактысы натыйжалардын кандайча чечмеленишине таасир этиши мүмкүн.
Активдүү B12 жана MMA дарылоодон кийин канчалык эрте кайра текшерилиши керек?
Активдүү B12 жана MMA көбүнчө 8–12 жума бою ырааттуу B12 дарылоосунан кийин кайра текшерилет. MMA 1–3 жуманын ичинде төмөндөшү мүмкүн, бирок симптомдор жана CBC өзгөрүүлөрү узагыраак убакыт талап кылынышы мүмкүн. Неврологиялык калыбына келүү көбүнчө 3–12 айга созулат, ал эми тең салмактуулуктун начарлашы, алсыздык же уйкусуроо күчөсө, пландуу кайра текшерүүнү күтпөстөн эртерээк карап чыгуу керек.
Бүгүн AI менен күчөтүлгөн кан анализин талдоону алыңыз
Дүйнө жүзү боюнча 2 миллиондон ашык колдонуучу Kantestiти заматта, так лабораториялык анализ талдоосу үчүн ишенет. Кан анализиңизди жүктөп, бир нече секунд ичинде 15,000+ биомаркерлеринин комплекстүү чечмелөөсүн алыңыз.
📚 Шилтемеленген изилдөө басылмалары
Klein, T., Mitchell, S., & Weber, H. (2026). aPTT нормалдуу диапазону: D-димер, С протеини боюнча кандын уюшу боюнча колдонмо. Kantesti AI медициналык изилдөө.
Klein, T., Mitchell, S., & Weber, H. (2026). Кан сары суусунун белоктору боюнча колдонмо: Глобулиндер, альбуминдер жана A/G катышы боюнча кан анализи. Kantesti AI медициналык изилдөө.
📖 Тышкы медициналык шилтемелер
⚕️ Медициналык эскертүү
Бул макала билим берүү максатында гана жана медициналык кеңеш болуп саналбайт. Диагноз коюу жана дарылоо чечимдери үчүн дайыма квалификациялуу саламаттыкты сактоо адисине кайрылыңыз.
E-E-A-T ишеним сигналдары
Тажрыйба
Дарыгер жетектеген лабораториялык чечмелөө иш процесстерин клиникалык кароо.
Экспертиза
Биомаркерлер клиникалык контекстте кандай жүрөрүнө лабораториялык медицина багыты.
Авторитеттүүлүк
Доктор Томас Клейн жазган, доктор Сара Митчелл жана профессор доктор Ханс Вебер тарабынан каралган.
Ишенимдүүлүк
Тынчсызданууну азайтуу үчүн так кийинки кадамдар менен далилге негизделген чечмелөө.